Results 161 to 170 of about 33,477 (277)

Practical Considerations for the Design, Conduct, and Reporting of Clinical Pharmacokinetic Drug–Drug Interaction Studies in Drug Development

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 11, November 2026.
Abstract Clinical pharmacokinetic drug–drug interaction (PK‐DDI) studies are frequently required in drug development when metabolizing enzymes and transporters determine pharmacokinetics. Drugs can be victims, perpetrators, or victims and perpetrators, of PK‐DDIs, so the clinical consequences of these interactions, particularly the risks of severe ...
Thomas M. Polasek, John O. Miners
wiley   +1 more source

Target Trial Emulation or Target Trial Approximation?

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Target trial emulation has contributed to improvements in the design and interpretation of observational studies aimed at causal inference. By encouraging researchers to think explicitly about the design of a hypothetical randomized trial, it has helped identify and address avoidable design flaws.
Priya Vart
wiley   +1 more source

Integrated Reproductive and Cytogenetic Assessment of Infertility in a Captive Jaguar (Panthera onca)

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
Integrated reproductive and cytogenetic assessment of infertility in a captive jaguar pair identified normal chromosomal status in both individuals, whereas impaired semen quality in the male likely represents a major limiting factor for reproductive success under the observed conditions.
Marie Altmanová   +3 more
wiley   +1 more source

Histological Findings in Testes of Baboons (Papio spp.) and Dwarf Bucks (Capra hircus) Subject to Repeated Immunisation Against GnRH

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
Long‐term repeated immunisation against GnRH resulted in the absence of active spermatogenesis and may lead to irreversible infertility in dwarf bucks and baboons. Histological examination revealed a marked reduction of the seminiferous tubular lumen, complete depletion of germ cells, germ cell vacuolization and tubular hyalinization.
Teresa Ferrín   +8 more
wiley   +1 more source

Influencing Factors Associated With Infantile Hemangioma: A Case–Control Study Among Chinese Pediatric Populations

open access: yesThe Journal of Dermatology, Volume 53, Issue 11, Page 1591-1598, November 2026.
ABSTRACT Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. While its epidemiology is well‐documented in Caucasian populations, large‐scale systematic studies regarding clinical characteristics and risk factors in the Chinese population remain limited.
Xinyu Liu   +4 more
wiley   +1 more source

How we treat venous thromboembolism in pregnancy in a resource‐limited setting

open access: yes
HemaSphere, Volume 10, Issue 11, November 2026.
Theresa Nwagha   +5 more
wiley   +1 more source

Sugammadex interference with serum progesterone measurement: an in‐vitro study

open access: yesAnaesthesia, Volume 81, Issue 11, Page 1489-1496, November 2026.
Summary Introduction Sugammadex may interfere with serum progesterone immunoassays, potentially rendering measured concentrations and resulting recommendations unreliable. Methods We investigated the effect of a range of sugammadex concentrations on serum progesterone concentrations in samples from pre‐menopausal female volunteers.
Tamblyn Devoy   +5 more
wiley   +1 more source

Elevated cardiovascular risk associated with hormone replacement therapy: A comprehensive analysis of reproductive factors and atherosclerotic cardiovascular disease outcomes in the UK Biobank cohort

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 11, Page 2183-2194, November 2026.
Among 170,250 UK Biobank women (2006–2024), ever HRT use was associated with higher incident ASCVD risk (adjusted HR 1.13, 95% CI 1.08–1.18), largely driven by ischemic stroke. Associations were stronger in women ≤45 years and during perimenopause. Mediation via sex hormones, inflammatory markers, or lipids was minimal (<2%).
Mengchun Wang   +6 more
wiley   +1 more source

Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland

open access: yesActa Ophthalmologica, Volume 104, Issue 7, Page 742-749, November 2026.
Abstract Purpose Hormonal replacement therapy (HRT) in postmenopausal women appears to affect glaucoma risk, but findings are inconsistent. We aimed to explore whether the use of postmenopausal HRT plays a role in glaucoma development in Finland. Methods The main outcome variable was glaucoma incidence measured by initiation of special reimbursement ...
Sirpa Loukovaara, Jari Haukka
wiley   +1 more source

Home - About - Disclaimer - Privacy